- Final NDA submission for COMP360 to be filed in the next two weeks; target launch in H1 2027 pending FDA approval.
- Net loss narrowed to $9.8M ($0.07/share basic) aided by fair value gains.
- Cash and equivalents stood at $444.0M vs $149.6M at year-end 2025; debt rose to $51.0M.
Signal #114457 · SEC 8-K
$CMPS SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $CMPS filing catalyst
Why did $CMPS trigger an AI stock catalyst alert?
$CMPS triggered a Stock Catalyst AI alert on 2026-11-03 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: COMPASS Pathways Reports Q3 Results; NDA Filing Imminent in Next Two Weeks. Key points: - Final NDA submission for COMP360 to be filed in the next two weeks; target launch in H1 2027 pending FDA approval. - Net loss narrowed to $9.8M ($0.07/share basic) aided by fair value gains. - Cash and equivalents stood at $444.0M vs $149.6M at year-end 2025; debt rose to $51.0M.
How did $CMPS stock react after the SEC filing?
After the SEC 8-K for $CMPS, observed market reaction: T0 price $8.41. Past moves do not guarantee future results.
Where can I get real-time $CMPS SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $CMPS via Telegram and the VIP Web Terminal from €10/month.